Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours

Research output: Contribution to journalArticle

Authors

  • U Srirangalingam
  • B Khoo
  • L Walker
  • Fiona MacDonald
  • RH Skelly
  • E George
  • David Spooner
  • LB Johnston
  • JP Monson
  • AB Grossman
  • WM Drake
  • SA Akker
  • PJ Pollard
  • N Plowman
  • N Avril
  • DM Berney
  • JM Burrin
  • RH Reznek
  • VKA Kumar
  • SL Chew

Abstract

Mutations in succinate dehydrogense-B (SDHB) and the von Hippel-Lindau (VHL) genes result in an increased risk of developing chromaffin tumours via a common aetiological pathway. The aim of the present retrospective study was to compare the clinical phenotypes of disease in subjects developing chromaffin tumours as a result of SDHB mutations or VHL disease. Thirty-one subjects with chromaffin tumours were assessed; 16 subjects had SDHB gene mutations and 15 subjects had a diagnosis of VHL. VHL-related tumours were predominantly adrenal phaeochromocytomas (22/26; 84.6%), while SDHB-related tumours were predominantly extra-adrenal paragangliomas (19/25; 76%). Median age at onset of the first chromaffin tumour was similar in the two cohorts. Tumour size was significantly larger in the SDHB cohort in comparison with the VHL cohort (P = 0.002). Multifocal disease was present in 9/15 (60%) of the VHL cohort (bilateral phaeochromocytomas) and only 3/16 (19%) of the SDHB cohort, while metastatic disease was found in 5/16 (31%) of the SDHB cohort but not in the VHL cohort to date. The frequency of symptoms, hypertension and the magnitude of catecholamine secretion appeared to be greater in the SDHB cohort. Renal cell carcinomas were a feature in 5/15 (33%) of the VHL cohort and 1/16 (6%) of the SDHB cohort. These data indicate that SDHB-related tumours are predominantly extra-adrenal in location and associated with higher catecholamine secretion and more malignant disease, in subjects who appear more symptomatic. VHL-related tumours tend to be adrenal phaeochromocytomas, frequently bilateral and associated with a milder phenotype.

Details

Original languageEnglish
Pages (from-to)515-525
Number of pages11
JournalEndocrine-related cancer
Volume16
Issue number2
Publication statusPublished - 1 Jun 2009